Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C - Clinical and virologic implications

Transplantation

Volumn 68, Issue 10, 1999, Pages 1512-1516

  Dickson, Rolland C ^a,c   Mizokami, Masashi ^b   Orito, Etsuro ^b   Qian, KePing ^a   Lau, Johnson Y N ^a,d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c MAYO CLINIC   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIGEN;

ADULT; AGED; ARTICLE; ENZYME IMMUNOASSAY; FLUORESCENCE; GENE AMPLIFICATION; GENOTYPE; HEPATITIS C; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ASSAY; RECURRENT DISEASE; VIREMIA;

EID: 0033610635     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199911270-00014     Document Type: Article

References (24)

1. Alter MJ. The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents Dis 1993; 2: 155.
2. Ascher NL, Lake JR, Edmond J, Roberts J Liver transplantation for hepatitis C virus -related cirrhosis. Hepatology 1994: 20: 24S.
3. Davis GL, Lau JYN, Urdea MS, et al. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994; 19: 1337.
4. Ohno T, Lau JYN. The "gold-standard", accuracy, and the current concepts: hepatitis C virus genotype and viremia. Hepatology 1996; 24: 1312.
5. Detmer J, Lagier R, Flynn F, et al. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol 1996; 34: 901.
6. Hollingsworth RC, Sillekens P, van-Deursen P, Neal KR, Irving WL. Serum HCV levels assessed by quantitative NASBA: stability of viral load over time, and lack of correlation with liver disease. The Trent HCV Study Group. J Hepatol 1996; 25: 301.
7. Tanaka T, Lau JYN, Mizokami M, et al. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J Hepatology 1995; 23: 742.
8. Detmer J, Lagier R, Flynn F, et al. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol 1996; 34: 9018
9. Lau -JY, Mizokami M, Kolberg JA, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995; 171: 281.
10. Simmonds P, Alberti A, Bonino F, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321.
11. Saito M, Hasegawa A, Kashiwakuma T, et al. Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (c11/c7). Clin Chem 1992; 38/12: 2434.
12. Jacob S, Baudy D, Jones E, et al. Comparison of quantitative HCV RNA assays in chronic hepatitis C. Am J Clin Pathol 1997; 107: 362
13. Donegan E, Wright TL, Roberts J, et al. Detection of hepatitis C after liver transplantation. Four serologic tests compared. Am J Clin Pathol. 1995; 104: 673.
14. Konig V, Bateaux J, Lobeck H, et al. Hepatitis C Reinfection in allografts after orthotopic liver transplantation. Hepatology 1992; 16: 1137
15. Wright T, Donegan E, Hsu H, et al. Recurrent and acquired Hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317.
16. Zhou S, Terrault NA, Ferrell L, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996; 24: 1041:
17. Asanza CG, Garcia-Monzon C, Clemente G, et al. Immunohisto-chemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation. Hepatology 1997; 267: 55.
18. Duvoux C, Pawlotsky JM, Cherqui D, et al. Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. A useful test for diagnosis of hepatitis C virus reinfection. Transplantation 1995; 60: 457-61
19. Gane EJ, Naumov NV, Quian KP et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110: 167.
20. Di Martino V, Saurini F, Samuel D, et al. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation Hepatology 1997; 26: 1343.
21. Gayowski T, Singh N, Marino IR et al. Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 1997; 64: 422.
22. Gordon FD, Poterucha JJ, Germer J, et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 1997; 63: 1419.
23. Shuhart MC, Bronner MP, Gretch DR, et al. Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology 1997; 26: 1646
24. Belli LS, Silini E, Alberti A, et al. Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation. Liver Transplant Surg1996; 2: 200.